Mumbai A division bench of the Delhi High Court on Wednesday ordered Dr Reddy's Labs to file its reply to the injunction petition moved by Danish drug maker Novo Nordisk for its blockbuster weight-loss drug semaglutide, which is sold under the brand name Wegovy.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
You may also like
Chip shop's battered Aldi caterpillar cake has people 'horrified yet intrigued'
France, First G7 State's Recognition Of Palestine Stirs Global Debate
Maradona's 'Hand of God' named most notorious moment in football history
Toto Wolff addresses role in Christian Horner sacking after wild Max Verstappen theory
UP Minister Pratibha Shukla Protests At Kanpur Dehat Police Station Against Alleged Fake SC/ST Case (VIDEO)
